| Literature DB >> 26595812 |
Jing Wu, Mohamed A Saleh, Annet Kirabo, Hana A Itani, Kim Ramil C Montaniel, Liang Xiao, Wei Chen, Raymond L Mernaugh, Hua Cai, Kenneth E Bernstein, Jörg J Goronzy, Cornelia M Weyand, John A Curci, Natalia R Barbaro, Heitor Moreno, Sean S Davies, L Jackson Roberts, Meena S Madhur, David G Harrison.
Abstract
Vascular oxidative injury accompanies many common conditions associated with hypertension. In the present study, we employed mouse models with excessive vascular production of ROS (tg(sm/p22phox) mice, which overexpress the NADPH oxidase subunit p22(phox) in smooth muscle, and mice with vascular-specific deletion of extracellular SOD) and have shown that these animals develop vascular collagen deposition, aortic stiffening, renal dysfunction, and hypertension with age. T cells from tg(sm/p22phox) mice produced high levels of IL-17A and IFN-γ. Crossing tg(sm/p22phox) mice with lymphocyte-deficient Rag1(-/-) mice eliminated vascular inflammation, aortic stiffening, renal dysfunction, and hypertension; however, adoptive transfer of T cells restored these processes. Isoketal-protein adducts, which are immunogenic, were increased in aortas, DCs, and macrophages of tg(sm/p22phox) mice. Autologous pulsing with tg(sm/p22phox) aortic homogenates promoted DCs of tg(sm/p22phox) mice to stimulate T cell proliferation and production of IFN-γ, IL-17A, and TNF-α. Treatment with the superoxide scavenger tempol or the isoketal scavenger 2-hydroxybenzylamine (2-HOBA) normalized blood pressure; prevented vascular inflammation, aortic stiffening, and hypertension; and prevented DC and T cell activation. Moreover, in human aortas, the aortic content of isoketal adducts correlated with fibrosis and inflammation severity. Together, these results define a pathway linking vascular oxidant stress to immune activation and aortic stiffening and provide insight into the systemic inflammation encountered in common vascular diseases.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26595812 PMCID: PMC4701546 DOI: 10.1172/JCI80761
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808